Urgent Notice to All Conference Participants

It has been brought to our attention that EHS Housing has recently been cold calling our speakers offering accommodation for a named Fusion conference. Please note that we have no association with EHS Housing and they are acting on our behalf without our permission. We strongly advise that any calls from EHS Housing are ignored or ended immediately. If you are contacted by EHS Housing, please notify us immediately.

All Fusion registration fees are inclusive of accommodation (for three fixed nights) and reservations are handled internally, entirely by Fusion Conferences. If you have any questions concerning your accommodation, please contact Fusion Conferences directly via admin@fusion-conferences.com.

Latest News:
Follow us

Home > Past Conferences > Cardiovascular Disease Prevention

The registration process for this conference has now closed.

Registration Deadlines

Talk Submission – expired

Poster Submission – expired

Early bird – expired

Last Chance – expired

Cardiovascular Disease Prevention

Novel Strategies and Emerging Therapies

14 Feb 14 - 17 Feb 14

Cancun, Mexico

Synopsis

CME Accreditation 
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit(s)™.

This meeting has also been endorsed by the American Society for Preventive Cardiology, the World Heart Federation, the International Academy of Cardiology and the California Chapter of the American College of Cardiology.

Learning Objectives:

1) Understand the latest guidelines for CVD risk assessment, modalities for screening for CVD, and their role in prevention
2) Evaluate the role of comprehensive lifestyle management approaches including diet, physical activity, and stress management in the prevention of CVD
3) Evaluate the relative importance of different lipid parameters and the role of emerging therapies for dyslipidemia for management of lipid disorders, including familial hypercholesterolemia
4) Evaluate the relation of diabetes with CVD and the role of CVD risk factor modification for prevention of CVD in diabetes. 
5) We also will be discussing the long-awaited revised ACC/AHA prevention guidelines within our sessions on CVD risk assessment, dyslipidemia, and lifestyle/obesity and invite your participation in these discussions.

Key Sessions:

  1. CVD Risk Assesment & Imaging
  2. Lifestyle Management
  3. Metabolicy Syndrome, Diabetes, Other Comorbidities 
  4. Dyslipidemia & Hypertension
  5. ACC/AHA Prevention Guidelines Update
  6. Implementing Preventive and Rehabilitative Programes
  7. Special Populations
  8. Potpouri

Confirmed Invited Speakers:

Dr. Ezra Amsterdam, UC Davis Health System
Dr. Seth Baum, Boca Raton Regional Hospital
Dr. Shaista Malik, University of California, Irvine
Ms. Geeta Sikand, University of California, Irvine
Professor Stanley Bassin, University of California, Irvine
Dr. Francisco Lopez Jimenez, Mayo Clinic, Minnesota
Dr. Tom Allison, Mayo Clinic, Minnesota
Dr. Manlio Marquez, Instituto Nacional de Cardiologia

Confirmed Lecture Topics will include;

Components of Evidence Based Diets for Prevention of Heart Disease.
Evidence for Prevention of Cardiovascular Disease: Do Vegetarian Diets Work?
Heart Disease in Women: A Fresh Perspective.
Update on the Management of Hypertension: New Understanding, New Therapy.
Wading through the Sea of Fish Oil Choices; How do we Sort Science from Marketing.
Dissecting Women’s Lipids and Lipoproteins: Clues to their Hidden Residual Risk.
Which stress to order and how to interpret.
Sports cardiology interesting cases.
Women's heart disease: are the differences greater than the similarities.
Role of imaging in preventing heart disease.
Multidisciplinary Framework for a Preventive Cardiology Program (with Drs. Malik and Sikand).
Strategies that work to Reduce Obesity and increase Physical Activity among Young People.
Lipid Management Beyond LDL-C: Is there a Role of HDL-C and Newer Therapies.
Metabolic Syndrome, Diabetes, and CVD.
Statin Intolerance : Does it Exist? How to Manage?
Contemporary Lipid Markers of CV Risk.
Normal weight obesity: A risk factor or an oxymoron?
Sudden cardiac death in the general population: How can it be prevented.
Sudden cardiac death in athletes: possible strategies for prevention.
Cardiac rehabilitation for secondary prevention in CAD.

Sponsors

Programme

TBC

Speakers

Invited Speakers

  • Dr. Manlio Márquez
    Attached Doctor to the Service of Electrocardiology, Instituto Nacional de Cardiologia
  • Ms Geeta Sikand
    Associate Clinical Professor of Medicine Cardiology, University of California Irvine College of Medicine
  • Dr. Stan Bassin
    Clinical Professor of Medicine, University Of California,Irvine Medical Center, Division of Cardiology
  • Dr. Seth Baum
    Medical Director, Women's CVD Prevention, Boca Raton Regional Hospital
  • Dr Shaista Malik
    Assistant Professor, UC Irvine
  • Dr. Ezra Amsterdam
    Associate Chief (Academic Affairs) of Cardiovascular Medicine, UC Davis Medical Center
  • Dr. Thomas G. Allison
    Consultant, Cardiovascular Diseases and Internal Medicine, Mayo Clinic
  • Dr. Francisco Lopez-Jimenez
    Consultant, Mayo Clinic

Feedback

Sign In

Your feedback has been received.

Cant see images? See gallery on Flickr